Miller Jared D, Yousuf Omair, Berger Ronald D
Department of Medicine, Johns Hopkins University, Baltimore, MD.
Department of Medicine, Johns Hopkins University, Baltimore, MD.
Trends Cardiovasc Med. 2015 Oct;25(7):606-11. doi: 10.1016/j.tcm.2015.01.015. Epub 2015 Feb 7.
The implantable cardioverter-defibrillator (ICD) provides life-saving therapy to prevent sudden cardiac death. ICDs have been implanted in millions of patients worldwide since the first human implant in 1980. Clinical trials have helped establish guidelines for ICD implantation in primary and secondary prevention of sudden cardiac death. Recent trials have also tested and compared various programing strategies to avoid unnecessary shocks and improve survival among ICD recipients. ICDs may also assist with monitoring for heart failure management. In this review, we discuss the clinical science to date that has helped define the role of ICDs in current practice.
植入式心脏复律除颤器（ICD）提供挽救生命的治疗，以预防心源性猝死。自1980年首次植入人体以来，全球已有数百万患者植入了ICD。临床试验有助于确立ICD在心脏性猝死一级和二级预防中的植入指南。近期的试验还对各种程控策略进行了测试和比较，以避免不必要的电击并提高ICD植入者的生存率。ICD还可协助监测心力衰竭的管理。在本综述中，我们讨论了迄今为止有助于确定ICD在当前临床实践中作用的临床科学。
